Clinical Trial Update: NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effect of N-acetylcysteine on depressive symptoms in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Region Syddanmark | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED